Maropitant
From Self-sufficiency
| File:Maropitant.png | |
| Systematic (IUPAC) name | |
|---|---|
|
(7R,8S)-N-[(5-tert-Butyl-2-methoxyphenyl)methyl]-7-[di(phenyl)methyl]-1-azabicyclo[2.2.2]octan-8-amine | |
| Clinical data | |
| Routes of administration | Oral, subcutaneous |
| Legal status | |
| Legal status |
|
| Identifiers | |
| ATCvet code | QA04AD90 (WHO) |
| PubChem | CID 23724948 |
| Chemical data | |
| Formula | C32H40N2O |
| Molar mass | 468.67 g/mol[[Script error: No such module "String".]] |
Maropitant (Cerenia (US)), used as maropitant citrate (USAN), is a neurokinin (NK1) receptor antagonist, which was developed by Pfizer Animal Health specifically for the treatment of motion sickness and vomiting in dogs. It has not been approved by the FDA for use in any animal except dogs.[citation needed] It was approved for use on February 2007.
| 40x30px | This veterinary medicine–related article is a stub. You can help ssf by expanding it. |
See also
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." /> | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2009) |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from October 2009
- Articles with invalid date parameter in template
- Veterinary medicine stubs
- Articles lacking sources from October 2009
- All articles lacking sources
- 2Fix
- Dog health
- Quinuclidines
- Phenol ethers
